Novavax vaccine has become the first immune doses of vaccine to confirm the protection against new UK variant coronavirus disease which was detected in the UK last year.
A clinical trial involving 15,000 people in the UK found the vaccine produced by the American firm Novavax is 89.3 percent effective in preventing new coronavirus disease.
Prime Minister Boris Johnson says that it’s good news and confirmed that the UK will go ahead with the same vaccine